Company

Sepul Bio

Biotechnology Research Debilitating Conditions Like Ush2a-associated Retinitis Pigmentosa Click the Link in the Comments 👇 14 employees

Employees: 14
Contacts: 3
Emails: 3

Sepul Bio Overview

Headquarters: Debilitating Conditions Like Ush2a-associated Retinitis Pigmentosa Click the Link in the Comments 👇
Industry: Biotechnology Research
Employees: 14
Founded: 2023
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

RNA Therapies inherited retinal diseases Ophthalmics solutions

About Sepul Bio

As a Théa’s dedicated business unit, Sepul Bio is at the forefront of transformative RNA therapies for inherited retinal diseases, with a particular focus on the development of two cutting-edge ophthalmic medicines – Sepofarsen and Ultevursen. Consult our Social Media Community Guidelines: https://bit.ly/48pUFKm

Sepul Bio Contact Details

People in AeroLeads: 4
With contact data: 3
Email contacts: 3; 75.0% coverage

Sepul Bio Org Chart

Sample employees and titles

Name	Title	Location	Contact
Marloes Veenstra	Director Project Management at Sepul Bio		View
Michael Schwartz, M.s., Mba	Chief Operating Officer - Sepul Bio	Greater Philadelphia, United States	Email
Zuhal Butuner Od, Msc, Mba	Chief Medical Officer	Oakville, Ontario, Canada	Email
Andy Bolan	Director, Patient Advocacy at Sepul Bio	Amsterdam, North Holland, Netherlands	Email